본문 바로가기
KERD
논문KCI 등재

木瓜가 CT105와 βA로 誘導된Alzheimer's Disease病態 모델에 미치는 影響

The Effects of Chaenomelis fructus,(CMF) Extract on the Alzheimer's Disease Model Induced by CT-105 and βA

1

조회

0

다운로드

5

인용

0

참고문헌

주제분류한의학

초록

Abstract

This research investigates the effect of the Chaenomelis fructus(CMF) on Alzheimer's disease. Specifically, the effects of the CMF extract on (1) IL-1β, IL-6, and TNF-α mRNA of PC-12 cells treated with LPS; (2) amyloid precursor proteins(APP), acetylcholinesterase(AChE), and glial fibrillary acidic protein(GFAP) mRNA of PC-12 cells treated with CT-105; (3) the AChE activity and the APP production of PC-12 cell treated with CT-105; (4) the behavior of AD mice with βA; (5) expression of IL-1β, TNF-α, MDA, IL-1β mRNA, TNF-α mRNA, and ROS; (6) the infarction area of the hippocampus, and brain tissue injury in Alzheimer's diseased mice induced with βA were investigated. The results were summarized as follows ; 1. The CMF extract suppressed the expression of IL-1β, IL-6 and TNF-α mRNA in THP-1 cells treated with LPS. 2. The CMF extract suppressed the expression of APP, AChE, and GFAP mRNA in PC-12 cells treated with CT-105. 3. The CMF extract suppressed the AChE activity, and the production of APP significantly in PC-12 cells treated with CT-105. 4. A significant inhibitory effect on the memory deficit was shown on the CMF extract group of the mice with Alzheimer's disease induced by βA in the Morris water maze experiment, which measured stop-through latency, and distance movement-through latency. 5. The CMF extract suppressed the over-expression of IL-1β protein, TNF-α protein, MDA, IL-1β mRNA, TNF-α mRNA, CD68/GFAP, and ROS in the mice with Alzheimer's disease induced by βA. 6. The CMF extract reduced the infarction area of hippocampus, and controlled the injury of brain tissue in the mice with Alzheimer's disease induced by βA. These results suggest that the CMF extract may be effective for the treatment of Alzheimer's disease. Investigation into the clinical use of the CMF extract for Alzheimer's diseaseis suggested for future research.

참고문헌 (34)

  1. "圖解腦神經外科學", pp.27~31 (1992)
  2. "國譯石室秘錄", pp.102~ (1984)
  3. "The E280A presenilin 1 Alzheimer mutation produces increased Aβ 42 deposition and severe cerebellar pathology", 2(10), pp.1146~50 (1996)
  4. "The importance of inflammatory mechanisms in Alzheimer disease", 33(5), pp.371~8 (1998)
  5. "Suppression of an amyloid beta peptide-mediated calcium channel response by a secreted beta-amyloid precursor protein", 95(1), pp.1~4 (2000)
  6. "Biochemical and neurobehavioral profile of CHF2819 orally active acetylcholinesterase inhibitor for Alzheimer's disease", 294(1), pp.187~94 (2000)
  7. "Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain", 101(1), pp.89~100 (2000)
  8. "Review of the acetylcholinesterase inhibitor galanthamine", 9(10), pp.2393~402 (2000)
  9. "實用中醫內科學", pp.378~81 (1989), 上海科學技術出版社
  10. "모과의 성분에 관한 연구", 20(1), pp.10~2 (1989)
  11. "New colorimetric cytotoxicity assay for anticancer drug screening", 82(13), pp.1107~12 (1990)
  12. "Linearization of the Bradford protein assay increases its sensitivity", 236(2), pp.302~8 (1996)
  13. "Serum lipoperoxide levels in patients suppering from liver disease", pp.267~770 (1977)
  14. "동의정신의학", pp.256~71 (1992)
  15. "노인생활실태 분석 및 정책과제", pp.114~32 (1994)
  16. "Comprehensive textbook of psychiatry V", pp.2014~9 (1989)
  17. "成人病 老人病學", pp.225~8 (1992)
  18. "Alzheimer병 신경병리학적 소견과 분자생물학적 연구동향", 16(3), pp.323~38 (1997)
  19. "Clinical Neurology", 1, pp.120~9 (1991)
  20. "Toxic effect of the beta-amyloid precursor protein C-terminus fragment and Na+", Ca2+ gradients, 2000, pp.11(15), 3357~60
  21. "Gene transfer into the nervous system", 1(4), pp.339~71 (1987)
  22. "Mechanisms of amyloid beta protein-induced modification in ion transport systems implications for neurodegenerative diseases", 21(3), pp.173~213 (2001)
  23. "In vitro and in vivo studies investigating possible antioxidant actions of nicotine relevance to Parkinson's and Alzheimer's diseases", 1454(2), pp.143~52 (1999)
  24. "Comparative studies of huperzine A and tacrine on behavior and cholinesterase activities", 60(2), pp.377~86 (1998)
  25. "Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus", 76(1), pp.177~86 (1997)
  26. "FcepsilonRII", CD23 is expressed in Parkinson's disease and induces production of nitric oxide and tumor necrosis factor-alpha in glial cells, 1999, pp.19(9), 3440~7
  27. "The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia", 46(1), pp.35~8 (2001)
  28. "實用中醫腦病學", pp.242~51 (1993), 學苑出版社
  29. "從痰瘀論治老年期痴硏究進展", 31(10), pp.474~5 (1996)
  30. "ameliorates the impaired memory of rat in the Morris water maze", 272(1), pp.256~63 (1995)
  31. "In situ labeling of dying cortical neurons in normal aging and in Alzheimer‘s disease correlations with senile plaques and disease progression", 55, pp.1134~42 (1996)
  32. "ation of nuclear proteins in Alzheimer's disease", 122, pp.247~53 (1999), Increased poly
  33. "Multiple signals activate cleavage of membrane transforming growth factor-α precursor", 266, pp.5773~96 (1991)
  34. "-induced activation of BV-2 microglia", 12(7), pp.1449~52 (2001)

관련 논문AI추천

이 간행물의 다른 논문 (16건)